ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 207 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 2.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $4,000 | -89.2% | 500 | -88.5% | 0.00% | – |
| Q2 2015 | $37,000 | +1133.3% | 4,363 | +990.8% | 0.00% | – |
| Q1 2015 | $3,000 | -91.4% | 400 | -92.2% | 0.00% | – |
| Q4 2014 | $35,000 | 0.0% | 5,100 | -19.0% | 0.00% | – |
| Q3 2014 | $35,000 | -72.2% | 6,300 | -68.0% | 0.00% | -100.0% |
| Q2 2014 | $126,000 | +142.3% | 19,664 | +204.2% | 0.00% | +100.0% |
| Q1 2014 | $52,000 | +147.6% | 6,464 | +113.3% | 0.00% | – |
| Q4 2013 | $21,000 | -61.1% | 3,031 | +4.9% | 0.00% | -100.0% |
| Q3 2013 | $54,000 | +5300.0% | 2,890 | +3858.9% | 0.00% | – |
| Q2 2013 | $1,000 | – | 73 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $175,916,000 | 40.51% |
| Consonance Capital Management LP | 8,695,742 | $119,045,000 | 11.46% |
| Tamarack Advisers, LP | 3,700,000 | $49,358,000 | 7.76% |
| Opaleye Management Inc. | 1,045,000 | $14,306,000 | 7.49% |
| Granite Point Capital Management, L.P. | 457,415 | $6,262,000 | 2.44% |
| Redmile Group, LLC | 2,138,471 | $29,276,000 | 2.33% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 206,010 | $2,820,000 | 2.17% |
| Palo Alto Investors LP | 2,587,617 | $35,424,000 | 2.06% |
| PRICE MICHAEL F | 940,000 | $12,869,000 | 1.71% |
| HighVista Strategies LLC | 638,086 | $8,735,000 | 1.62% |